Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

<p><strong>Introduction:</strong> Less-invasive surfactant administration (LISA) is a method of surfactant delivery to preterm infants for treating respiratory distress syndrome (RDS), which can reduce the composite risk of death or bronchopulmonary dysplasia and the time on mechan...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Reynolds, P, Bustani, P, Darby, C, Fernandez Alvarez, JR, Fox, G, Jones, S, Robertson, SJ, Vasu, V, Roehr, CC
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Karger Publishers 2021

Míreanna comhchosúla

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
de réir: Ramaswamy, VV, et al.
Foilsithe / Cruthaithe: (2021)

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
de réir: Ramaswamy, VV, et al.
Foilsithe / Cruthaithe: (2021)

To sedate or not to sedate for less invasive surfactant administration: an ethical approach
de réir: Peterson, J, et al.
Foilsithe / Cruthaithe: (2021)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
de réir: Breindahl, N, et al.
Foilsithe / Cruthaithe: (2023)

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus
de réir: Jing Liu, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Efficacy of non‐invasive respiratory support modes for primary respiratory support in preterm neonates with Respiratory Distress Syndrome: Systematic review and network meta‐analysis
de réir: Ramaswamy, VV, et al.
Foilsithe / Cruthaithe: (2020)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
de réir: S. A. Perepelitsa, et al.
Foilsithe / Cruthaithe: (2009-10-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
de réir: Suada Heljić, et al.
Foilsithe / Cruthaithe: (2009-08-01)

Surfactant and respiratory distress syndrome
de réir: A D Milner
Foilsithe / Cruthaithe: (1996-01-01)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
de réir: Anna Tarocco, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome
de réir: Espinosa, Frank F. (Frank Francis)
Foilsithe / Cruthaithe: (2005)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
de réir: Anna Tarocco, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
de réir: S. A. Perepelitsa, et al.
Foilsithe / Cruthaithe: (2007-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
de réir: S. A. Perepelitsa
Foilsithe / Cruthaithe: (2014-08-01)

Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensus
de réir: Segundo Rite Gracia, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome
de réir: Chutinun Wongkhonkaen, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Clinical efficacy of using pulmonary surfactant at different times in the treatment of neonatal respiratory distress syndrome
de réir: ZHU Ling, et al.
Foilsithe / Cruthaithe: (2023-12-01)

An uncommon cause of neonatal respiratory distress
de réir: Gabriel Dimitriou, et al.
Foilsithe / Cruthaithe: (2010-12-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
de réir: İ.A. Mirzayeva, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Exogenous surfactant therapy in non-respiratory distress syndrome
de réir: A Greenough
Foilsithe / Cruthaithe: (1996-01-01)

Surfactant BL-Induced Changes in Blood Gas Composition and Acid-Base Balance In Neonatal Respiratory Distress Syndrome
de réir: S. A. Perepelitsa, et al.
Foilsithe / Cruthaithe: (2006-08-01)

Laryngeal Mask Airway Method for Minimally Invasive Surfactant Therapy in Neonates with Pneumothorax Complicating Respiratory Distress Syndrome
de réir: Joaquim M. B. Pinheiro, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis
de réir: Moschino, L, et al.
Foilsithe / Cruthaithe: (2022)

Surfactant as a drug carrier
de réir: Sett, A, et al.
Foilsithe / Cruthaithe: (2023)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
de réir: Morteza Habibi, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Guidelines on the management of acute respiratory distress syndrome
de réir: Danny Francis McAuley, et al.
Foilsithe / Cruthaithe: (2019-10-01)

The Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome Treated by Minimally Invasive Surfactant Therapy and Non-Invasive Ventilation
de réir: Tzyy-Rong Huang, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Respiratory Distress and the Bacteria Causing Infection in the Neonates
de réir: Neihaya Heikmat Zaki
Foilsithe / Cruthaithe: (2012-06-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
de réir: Nilgün Köksal, et al.
Foilsithe / Cruthaithe: (2009-12-01)

Management of neonates with respiratory distress syndrome in resource-limited settings
de réir: Radhika Singh, et al.
Foilsithe / Cruthaithe: (2024-05-01)

INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate
de réir: Ali Naseh, et al.
Foilsithe / Cruthaithe: (2014-06-01)

Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome
de réir: Yupeng Lei, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
de réir: Ozge Sürmeli-Onay, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome
de réir: James F Lewis, et al.
Foilsithe / Cruthaithe: (1997-01-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
de réir: A. V. Vlasenko, et al.
Foilsithe / Cruthaithe: (2005-12-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
de réir: V. V. Moroz, et al.
Foilsithe / Cruthaithe: (2013-08-01)

The association between sex and neonatal respiratory distress syndrome
de réir: Keren Fang, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants
de réir: Chamindu C. Gunatilaka, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) – It is time to classify respiratory distress syndrome (RDS) in preterm neonates
de réir: Deepti Thandaveshwara, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
de réir: Hassan Boskabadi, et al.
Foilsithe / Cruthaithe: (2024-10-01)